Viridian is dedicated to improving patients’ lives through the discovery and development of RNA-based therapeutics, with a specific focus on microRNAs.

Biotechnology

Viridian Therapeutics

Shan Wu

Melissa Manno

Jason A. Leverone

Angela She

Mark Howansky

Steve Graunke

Partha Ghosh

Rochelle Summerfelt

Shula Pollard

Angela Doyle

Chelsea Gordon

Thomas Beetham

Kellie Dinapoli

Lucy Weng

Valerie Smith

Cindy Durkin

The Advisory Team at Viridian Therapeutics provides expert guidance on the strategic direction of RNA-based therapeutics development. Composed of seasoned advisors, the team leverages their vast experience in microRNA research and pharmaceutical development to inform decision-making, optimize project outcomes, and enhance patient-centric innovations.

Advisory Team

Scientific Team

Quality Control and Operations

Advisory Team

About

Team members

Other teams at Viridian Therapeutics

Scientific Team

Quality Control and Operations